Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy

Nadzeya V. Marozkina, Sean Yemen, Molly Borowitz, Lei Liu, Melissa Plapp, Fei Sun, Rafique Islam, Petra Erdmann-Gilmore, R. Reid Townsend, Cheryl F. Lichti, Sneha Mantri, Phillip W. Clapp, Scott H. Randell, Benjamin Gaston, Khalequz Zaman

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The endogenous signaling molecule S-nitrosoglutathione (GSNO) and other S-nitrosylating agents can cause full maturation of the abnormal gene product ΔF508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR). However, the molecular mechanism of action is not known. Here we show that Hsp70/Hsp90 organizing protein (Hop) is a critical target of GSNO, and its S-nitrosylation results in ΔF508 CFTR maturation and cell surface expression. S-nitrosylation by GSNO inhibited the association of Hop with CFTR in the endoplasmic reticulum. This effect was necessary and sufficient to mediate GSNO-induced cell-surface expression of ΔF508 CFTR. Hop knockdown using siRNA recapitulated the effect of GSNO on ΔF508 CFTR maturation and expression. Moreover, GSNO acted additively with decreased temperature, which promoted mutant CFTR maturation through a Hop-independent mechanism. We conclude that GSNO corrects ΔF508 CFTR trafficking by inhibiting Hop expression, and that combination therapies - using differing mechanisms of action - may have additive benefits in treating CF.

Original languageEnglish (US)
Pages (from-to)11393-11398
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume107
Issue number25
DOIs
StatePublished - Jun 22 2010
Externally publishedYes

Fingerprint

Cystic Fibrosis
Proteins
S-Nitrosoglutathione
Therapeutics
Cystic Fibrosis Transmembrane Conductance Regulator
Endoplasmic Reticulum
Small Interfering RNA
Temperature
Genes

Keywords

  • Cystic fibrosis transmembrane conductance regulator
  • S-nitrosoglutathione corrector
  • Treatment

ASJC Scopus subject areas

  • General

Cite this

Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy. / Marozkina, Nadzeya V.; Yemen, Sean; Borowitz, Molly; Liu, Lei; Plapp, Melissa; Sun, Fei; Islam, Rafique; Erdmann-Gilmore, Petra; Townsend, R. Reid; Lichti, Cheryl F.; Mantri, Sneha; Clapp, Phillip W.; Randell, Scott H.; Gaston, Benjamin; Zaman, Khalequz.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, No. 25, 22.06.2010, p. 11393-11398.

Research output: Contribution to journalArticle

Marozkina, NV, Yemen, S, Borowitz, M, Liu, L, Plapp, M, Sun, F, Islam, R, Erdmann-Gilmore, P, Townsend, RR, Lichti, CF, Mantri, S, Clapp, PW, Randell, SH, Gaston, B & Zaman, K 2010, 'Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy', Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 25, pp. 11393-11398. https://doi.org/10.1073/pnas.0909128107
Marozkina, Nadzeya V. ; Yemen, Sean ; Borowitz, Molly ; Liu, Lei ; Plapp, Melissa ; Sun, Fei ; Islam, Rafique ; Erdmann-Gilmore, Petra ; Townsend, R. Reid ; Lichti, Cheryl F. ; Mantri, Sneha ; Clapp, Phillip W. ; Randell, Scott H. ; Gaston, Benjamin ; Zaman, Khalequz. / Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy. In: Proceedings of the National Academy of Sciences of the United States of America. 2010 ; Vol. 107, No. 25. pp. 11393-11398.
@article{a01fb06ba93f442cb881afa67f3d7961,
title = "Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy",
abstract = "The endogenous signaling molecule S-nitrosoglutathione (GSNO) and other S-nitrosylating agents can cause full maturation of the abnormal gene product ΔF508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR). However, the molecular mechanism of action is not known. Here we show that Hsp70/Hsp90 organizing protein (Hop) is a critical target of GSNO, and its S-nitrosylation results in ΔF508 CFTR maturation and cell surface expression. S-nitrosylation by GSNO inhibited the association of Hop with CFTR in the endoplasmic reticulum. This effect was necessary and sufficient to mediate GSNO-induced cell-surface expression of ΔF508 CFTR. Hop knockdown using siRNA recapitulated the effect of GSNO on ΔF508 CFTR maturation and expression. Moreover, GSNO acted additively with decreased temperature, which promoted mutant CFTR maturation through a Hop-independent mechanism. We conclude that GSNO corrects ΔF508 CFTR trafficking by inhibiting Hop expression, and that combination therapies - using differing mechanisms of action - may have additive benefits in treating CF.",
keywords = "Cystic fibrosis transmembrane conductance regulator, S-nitrosoglutathione corrector, Treatment",
author = "Marozkina, {Nadzeya V.} and Sean Yemen and Molly Borowitz and Lei Liu and Melissa Plapp and Fei Sun and Rafique Islam and Petra Erdmann-Gilmore and Townsend, {R. Reid} and Lichti, {Cheryl F.} and Sneha Mantri and Clapp, {Phillip W.} and Randell, {Scott H.} and Benjamin Gaston and Khalequz Zaman",
year = "2010",
month = "6",
day = "22",
doi = "10.1073/pnas.0909128107",
language = "English (US)",
volume = "107",
pages = "11393--11398",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "25",

}

TY - JOUR

T1 - Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy

AU - Marozkina, Nadzeya V.

AU - Yemen, Sean

AU - Borowitz, Molly

AU - Liu, Lei

AU - Plapp, Melissa

AU - Sun, Fei

AU - Islam, Rafique

AU - Erdmann-Gilmore, Petra

AU - Townsend, R. Reid

AU - Lichti, Cheryl F.

AU - Mantri, Sneha

AU - Clapp, Phillip W.

AU - Randell, Scott H.

AU - Gaston, Benjamin

AU - Zaman, Khalequz

PY - 2010/6/22

Y1 - 2010/6/22

N2 - The endogenous signaling molecule S-nitrosoglutathione (GSNO) and other S-nitrosylating agents can cause full maturation of the abnormal gene product ΔF508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR). However, the molecular mechanism of action is not known. Here we show that Hsp70/Hsp90 organizing protein (Hop) is a critical target of GSNO, and its S-nitrosylation results in ΔF508 CFTR maturation and cell surface expression. S-nitrosylation by GSNO inhibited the association of Hop with CFTR in the endoplasmic reticulum. This effect was necessary and sufficient to mediate GSNO-induced cell-surface expression of ΔF508 CFTR. Hop knockdown using siRNA recapitulated the effect of GSNO on ΔF508 CFTR maturation and expression. Moreover, GSNO acted additively with decreased temperature, which promoted mutant CFTR maturation through a Hop-independent mechanism. We conclude that GSNO corrects ΔF508 CFTR trafficking by inhibiting Hop expression, and that combination therapies - using differing mechanisms of action - may have additive benefits in treating CF.

AB - The endogenous signaling molecule S-nitrosoglutathione (GSNO) and other S-nitrosylating agents can cause full maturation of the abnormal gene product ΔF508 cystic fibrosis (CF) transmembrane conductance regulator (CFTR). However, the molecular mechanism of action is not known. Here we show that Hsp70/Hsp90 organizing protein (Hop) is a critical target of GSNO, and its S-nitrosylation results in ΔF508 CFTR maturation and cell surface expression. S-nitrosylation by GSNO inhibited the association of Hop with CFTR in the endoplasmic reticulum. This effect was necessary and sufficient to mediate GSNO-induced cell-surface expression of ΔF508 CFTR. Hop knockdown using siRNA recapitulated the effect of GSNO on ΔF508 CFTR maturation and expression. Moreover, GSNO acted additively with decreased temperature, which promoted mutant CFTR maturation through a Hop-independent mechanism. We conclude that GSNO corrects ΔF508 CFTR trafficking by inhibiting Hop expression, and that combination therapies - using differing mechanisms of action - may have additive benefits in treating CF.

KW - Cystic fibrosis transmembrane conductance regulator

KW - S-nitrosoglutathione corrector

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=77954939833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954939833&partnerID=8YFLogxK

U2 - 10.1073/pnas.0909128107

DO - 10.1073/pnas.0909128107

M3 - Article

C2 - 20534503

AN - SCOPUS:77954939833

VL - 107

SP - 11393

EP - 11398

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 25

ER -